LCN2 outperformed the existing biomarkers (leukocytes, protein, lactate and glucose) in discriminating between BM and other CNS infections (including TBM and encephalitis) (Fig. 4(A) and (B)). This evidence concerns the gene LCN2 and encephalitis.